Silencing of farnesoid X receptor in human colon cancer by epigenetic mechanisms is associated with cancer progression.

被引：0
|
作者：
Thomas, Ann M. [1 ]
Zhan, Le [2 ]
Izzo, Julie [1 ]
Maru, Dipen [1 ]
Shureiqi, Imad [1 ]
Baladandayuthapani, Veera [1 ]
Liang, Han [1 ]
Guo, Grace L. [3 ]
Powis, Garth [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Kansas Med Ctr, Kansas City, KS USA
[3] Rutgers State Univ, Piscataway, NJ USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3561
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Correction: Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
    Junhui Yu
    Kui Yang
    Jianbao Zheng
    Wei Zhao
    Xuejun Sun
    Cancer Gene Therapy, 2022, 29 : 871 - 872
  • [32] Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer
    Dong, Xingchen
    Qi, Ming
    Cai, Chunmiao
    Zhu, Yu
    Li, Yuwenbin
    Coulter, Sally
    Sun, Fei
    Liddle, Christopher
    V. Uboha, Nataliya
    Halberg, Richard
    Xu, Wei
    Marker, Paul
    Fu, Ting
    JCI INSIGHT, 2024, 9 (02)
  • [33] THE ROLE OF TOLL-LIKE RECEPTOR 4 IN BLADDER CANCER PROGRESSION.
    Fukawa, Tomoya
    Shintani, Terumichi
    Daizumoto, Kei
    Fukumori, Tomoharu
    Takahashi, Masayuki
    Kanayama, Hiro-omi
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1319 - E1319
  • [34] Discordance in hormone receptor status in breast cancer during tumor progression.
    Karlsson, E.
    Lindstrom, L. S.
    Wilking, U.
    Skoog, L.
    Johansson, U.
    Bergh, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] The epigenetic function of androgen receptor in prostate cancer progression
    Sawada, Takahiro
    Kanemoto, Yoshiaki
    Kurokawa, Tomohiro
    Kato, Shigeaki
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [36] Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer
    Kamikihara, T
    Arima, T
    Kato, K
    Matsuda, T
    Kato, H
    Douchi, T
    Nagata, Y
    Nakao, M
    Wake, N
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (05) : 690 - 700
  • [37] Expression of Type 2 Orexin Receptor in Human Endometrium and Its Epigenetic Silencing in Endometrial Cancer
    Dehan, P.
    Canon, C.
    Trooskens, G.
    Rehli, M.
    Munaut, C.
    Van Criekinge, W.
    Delvenne, P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (04): : 1549 - 1557
  • [38] Defining cancer-specific epigenomic signature associated with glioma progression.
    Noushmehr, Houtan
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 19 - 19
  • [39] miRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer
    Nie, Xiaobo
    Liu, Huiyang
    Wei, Xiaoyun
    Li, Lanqing
    Lan, Linhua
    Fan, Lili
    Ma, Han
    Liu, Lei
    Zhou, Yun
    Hou, Ruifang
    Chen, Wei-Dong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8025 - 8035
  • [40] The antiapoptotic role of pregnane x receptor in human colon cancer cells
    Zhou, Jie
    Liu, Mingjie
    Zhai, Yonggong
    Xie, Wen
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (04) : 868 - 880
12345